Additional mutations, e.g., in KRAS, PTEN, PIK3CA, TGFBR1, TGFBR2, SMAD2, SMAD4, and TP53 are found in APC-mutated sporadic CRC, which promote tumor progression. Here, APC is linked to neoplasm.